FT
Fast Track Initiative
Venture CapitalActiveFast Track Initiative is a venture capital firm with an exclusive focus on life sciences and healthcare services.
27
Investments
1
Exits
—
AUM
3.7%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Fast Track Initiative.
Investment Thesis & Strategy
Fast Track Initiative invests in various stages of life sciences and healthcare services companies. They seek to partner with innovative companies in the healthcare sector.
Investment Activity
Deals per year over the last 6 years
3
20184
20190
20204
20210
20221
2023Portfolio Companies
Selected investments from their portfolio of 27 companies
A
Alumis
Biotech · Series B, 2023
V
Ventyx Biosciences
Biotech · Series B, 2021
T
Tessera Therapeutics
Biotech · Series A, 2021
K
Kriya Therapeutics
Biotech · Series A, 2021
O
Obsidio
Healthcare · Series A, 2021
V
Verve Therapeutics
Biotech · Series A, 2019
L
Lyell Immunopharma
Biotech · Series B, 2019
X
Xilio Therapeutics
Biotech · Series A, 2019
S
Sana Biotechnology
Biotech · Series A, 2019
R
Revolution Medicines
Biotech · Series B, 2018
C
Cerevance
Biotech · Series B, 2018
A
Aura Biosciences
Biotech · Series B, 2018
Frequently Asked Questions
Fast Track Initiative focuses on Series A, Series B, Series C+ stage investments.